These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 12598849

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ, Min YK, Ryu WS, Kwak JW, Ryoo UH.
    Arch Intern Med; ; 156(15):1693-700. PubMed ID: 8694668
    [Abstract] [Full Text] [Related]

  • 3. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M, Fait T, Kovar J, Poledne R, Ceska R.
    Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
    [Abstract] [Full Text] [Related]

  • 4. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC, Lien YR, Chen M, Cheng SP, Chen RJ, Chow SN.
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [Abstract] [Full Text] [Related]

  • 5. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B, Guzic-Salobir B, Sebestjen M, Keber I.
    Menopause; 2006 Jul; 13(4):643-50. PubMed ID: 16837886
    [Abstract] [Full Text] [Related]

  • 6. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 7. [Cyclical gestagen (MPA) supplement for continuous transdermal or oral estrogen substitution in postmenopause: modification of serum lipids].
    Hänggi W, Birkhäuser MH, Malek A, Peheim E, von Hospenthal JU.
    Geburtshilfe Frauenheilkd; 1993 Oct; 53(10):709-14. PubMed ID: 8270155
    [Abstract] [Full Text] [Related]

  • 8. Effect of early estrogen replacement therapy on microvascular reactivity in patients after bilateral ovarectomy.
    Prázný M, Fait T, Vrablik M.
    Neuro Endocrinol Lett; 2007 Aug; 28(4):496-501. PubMed ID: 17693976
    [Abstract] [Full Text] [Related]

  • 9. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 10. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA, Farias ML, Andrade AT.
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [Abstract] [Full Text] [Related]

  • 11. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW.
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [Abstract] [Full Text] [Related]

  • 12. Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate.
    Castelo-Branco C, Casals E, Sanllehy C, Duran M, Fortuny A, Vanrell JA.
    J Reprod Med; 1996 Nov; 41(11):833-8. PubMed ID: 8951134
    [Abstract] [Full Text] [Related]

  • 13. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
    Yuvaraj S, Premkumar VG, Vijayasarathy K, Gangadaran SG, Sachdanandam P.
    Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
    [Abstract] [Full Text] [Related]

  • 14. Effects of oral and transdermal hormone replacement therapy on lipoprotein(A) and lipids: a randomized controlled trial.
    Meschia M, Bruschi F, Soma M, Amicarelli F, Paoletti R, Crosignani P.
    Menopause; 1998 Jun; 5(3):157-62. PubMed ID: 9774761
    [Abstract] [Full Text] [Related]

  • 15. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T, Kostecka A, Rogatko I, Sztefko K, Kwiatkowska-Panek E, Radowick S, Krzysiek J.
    Przegl Lek; 2007 Jun; 64(2):65-9. PubMed ID: 17892034
    [Abstract] [Full Text] [Related]

  • 16. Short-term results of transdermal estrogen replacement therapy in cardiovascular disease-free postmenopausal females with and without hypertension.
    Modena MG, Rossi R, Muia N, Origliani G, Rombolà O, Molinari R.
    G Ital Cardiol; 1998 Jun; 28(6):636-44. PubMed ID: 9672776
    [Abstract] [Full Text] [Related]

  • 17. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M, Theppisai U, Manonai J, Suchartwatnachai C, Jorgensen LN.
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [Abstract] [Full Text] [Related]

  • 18. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance.
    Erenus M, Karakoç B, Gürler A.
    Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [Abstract] [Full Text] [Related]

  • 20. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
    Balci H, Altunyurt S, Acar B, Fadiloglu M, Kirkali G, Onvural B.
    Maturitas; 2005 Apr 11; 50(4):289-93. PubMed ID: 15780528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.